Clinical Trials Directory

Trials / Terminated

TerminatedNCT05740553

Automated Stereognosis to Treat Loss of Tactile Function After Brain Injury

Using the ReTrieve Automated Stereognosis System to Treat Loss of Tactile Function After Brain Injury

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
3 (actual)
Sponsor
The University of Texas at Dallas · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Researchers aim to determine whether the ReTrieve system for tactile training can improve tactile function (sense of touch) in the hand after brain injury when used at home for 6 weeks.

Detailed description

All participants who have been found eligible for this study and given informed consent will be randomized into two groups- either participants will begin ReTrieve training immediately following an initial assessment, or wait 8 weeks before beginning training. During the study, participants will have a ReTrieve tactile training system delivered home for use over 6 weeks. Investigators will take three days to teach participants how to use the system. Each week for the remainder of the 6 weeks, participants will use this system for 4+ days per week on their own, and for 1 day supervised. During each supervised day, participants will complete approximately 1 hour of training while supervised over video chat with researchers. Participants' tactile function will be assessed at three separate time points: once within one week before beginning training, once within one week after completing training, as well as once either 8 weeks before or 8 weeks after the training. This assessment has a required survey component, as well as an optional in-person clinical assessment component.

Conditions

Interventions

TypeNameDescription
DEVICEReTrieve Automated Stereognosis SystemAn automated tactile training system that may help patients recover lost tactile function after brain injury.

Timeline

Start date
2021-11-15
Primary completion
2022-06-06
Completion
2022-06-06
First posted
2023-02-23
Last updated
2023-03-06

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05740553. Inclusion in this directory is not an endorsement.